These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30409833)

  • 1. A Fentanyl Vaccine Alters Fentanyl Distribution and Protects against Fentanyl-Induced Effects in Mice and Rats.
    Raleigh MD; Baruffaldi F; Peterson SJ; Le Naour M; Harmon TM; Vigliaturo JR; Pentel PR; Pravetoni M
    J Pharmacol Exp Ther; 2019 Feb; 368(2):282-291. PubMed ID: 30409833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid Dose- and Route-Dependent Efficacy of Oxycodone and Heroin Vaccines in Rats.
    Raleigh MD; Laudenbach M; Baruffaldi F; Peterson SJ; Roslawski MJ; Birnbaum AK; Carroll FI; Runyon SP; Winston S; Pentel PR; Pravetoni M
    J Pharmacol Exp Ther; 2018 May; 365(2):346-353. PubMed ID: 29535156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological mechanisms underlying the efficacy of antibodies generated by a vaccine to treat oxycodone use disorder.
    Raleigh MD; King SJ; Baruffaldi F; Saykao A; Hamid FA; Winston S; LeSage MG; Pentel PR; Pravetoni M
    Neuropharmacology; 2021 Sep; 195():108653. PubMed ID: 34126123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and Characterization of Conjugate Vaccines to Reduce Opioid Use Disorders Suitable for Pharmaceutical Manufacturing and Clinical Evaluation.
    Baruffaldi F; Raleigh MD; King SJ; Roslawski MJ; Birnbaum AK; Hassler C; Carroll FI; Runyon SP; Winston S; Pentel PR; Pravetoni M
    Mol Pharm; 2019 Jun; 16(6):2364-2375. PubMed ID: 31018096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining a Candidate Vaccine for Opioid Use Disorders with Extended-Release Naltrexone Increases Protection against Oxycodone-Induced Behavioral Effects and Toxicity.
    Raleigh MD; Accetturo C; Pravetoni M
    J Pharmacol Exp Ther; 2020 Sep; 374(3):392-403. PubMed ID: 32586850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ampakine CX717 protects against fentanyl-induced respiratory depression and lethal apnea in rats.
    Ren J; Ding X; Funk GD; Greer JJ
    Anesthesiology; 2009 Jun; 110(6):1364-70. PubMed ID: 19461299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic and Prophylactic Vaccines to Counteract Fentanyl Use Disorders and Toxicity.
    Robinson C; Gradinati V; Hamid F; Baehr C; Crouse B; Averick S; Kovaliov M; Harris D; Runyon S; Baruffaldi F; LeSage M; Comer S; Pravetoni M
    J Med Chem; 2020 Dec; 63(23):14647-14667. PubMed ID: 33215913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of currently approved carriers and adjuvants on the pre-clinical efficacy of a conjugate vaccine against oxycodone in mice and rats.
    Pravetoni M; Vervacke JS; Distefano MD; Tucker AM; Laudenbach M; Pentel PR
    PLoS One; 2014; 9(5):e96547. PubMed ID: 24797666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and selectivity of a heroin conjugate vaccine to attenuate heroin, 6-acetylmorphine, and morphine antinociception in rats: Comparison with naltrexone.
    Schwienteck KL; Blake S; Bremer PT; Poklis JL; Townsend EA; Negus SS; Banks ML
    Drug Alcohol Depend; 2019 Nov; 204():107501. PubMed ID: 31479865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical Efficacy and Characterization of Candidate Vaccines for Treatment of Opioid Use Disorders Using Clinically Viable Carrier Proteins.
    Baruffaldi F; Kelcher AH; Laudenbach M; Gradinati V; Limkar A; Roslawski M; Birnbaum A; Lees A; Hassler C; Runyon S; Pravetoni M
    Mol Pharm; 2018 Nov; 15(11):4947-4962. PubMed ID: 30240216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal Antibodies Counteract Opioid-Induced Behavioral and Toxic Effects in Mice and Rats.
    Baehr C; Kelcher AH; Khaimraj A; Reed DE; Pandit SG; AuCoin D; Averick S; Pravetoni M
    J Pharmacol Exp Ther; 2020 Dec; 375(3):469-477. PubMed ID: 32980813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Profiling of Antifentanyl Monoclonal Antibodies in Combination with Naloxone in Pre- and Postexposure Models of Fentanyl Toxicity.
    Baehr CA; Wu MM; Pandit SG; Arias-Umana J; AuCoin D; Pravetoni M
    J Pharmacol Exp Ther; 2022 May; 381(2):129-136. PubMed ID: 35153198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of fentanyl-specific monoclonal antibody (mAb) to antagonize the pharmacological effects of fentanyl.
    Chen XY; Wang L; Ma X; Yang F; Wang X; Xu P; Xu LL; Di B
    Toxicol Appl Pharmacol; 2024 May; 486():116918. PubMed ID: 38570042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse.
    Raleigh MD; Peterson SJ; Laudenbach M; Baruffaldi F; Carroll FI; Comer SD; Navarro HA; Langston TL; Runyon SP; Winston S; Pravetoni M; Pentel PR
    PLoS One; 2017; 12(12):e0184876. PubMed ID: 29194445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacious Vaccine against Heroin Contaminated with Fentanyl.
    Hwang CS; Smith LC; Natori Y; Ellis B; Zhou B; Janda KD
    ACS Chem Neurosci; 2018 Jun; 9(6):1269-1275. PubMed ID: 29558798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Selectivity of Monovalent and Bivalent Vaccination Strategies to Protect against Exposure to Carfentanil, Fentanyl, and Their Mixtures in Rats.
    Crouse B; Wu MM; Gradinati V; Kassick AJ; Song D; Jahan R; Averick S; Runyon S; Comer SD; Pravetoni M
    ACS Pharmacol Transl Sci; 2022 May; 5(5):331-343. PubMed ID: 35592436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenytoin, midazolam, and naloxone protect against fentanyl-induced brain damage in rats.
    Sinz EH; Kofke WA; Garman RH
    Anesth Analg; 2000 Dec; 91(6):1443-9. PubMed ID: 11093997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of an oxycodone conjugate vaccine on oxycodone self-administration and oxycodone-induced brain gene expression in rats.
    Pravetoni M; Pentel PR; Potter DN; Chartoff EH; Tally L; LeSage MG
    PLoS One; 2014; 9(7):e101807. PubMed ID: 25025380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noradrenergic Mechanisms in Fentanyl-Mediated Rapid Death Explain Failure of Naloxone in the Opioid Crisis.
    Torralva R; Janowsky A
    J Pharmacol Exp Ther; 2019 Nov; 371(2):453-475. PubMed ID: 31492824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo profiling of seven common opioids for antinociception, constipation and respiratory depression: no two opioids have the same profile.
    Kuo A; Wyse BD; Meutermans W; Smith MT
    Br J Pharmacol; 2015 Jan; 172(2):532-48. PubMed ID: 24641546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.